Bristol-Myers Squibb
BMY
1,179 hedge funds and large institutions have $49.8B invested in Bristol-Myers Squibb in 2013 Q2 according to their latest regulatory filings, with 1,179 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
68.53% more ownership
Funds ownership: 0% → 68.53% (+69%)
1% more call options, than puts
Call options by funds: $519M | Put options by funds: $516M
Top Buyers
Top Sellers
BMY Hedge Fund Activity: Q2 2013 in Review
1,179 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q2 2013, worth a combined $49.8B.
Buyers outnumbered sellers: 1,179 funds opened new BMY positions and 0 closed out — a net gain of 1,179 holders — while 0 added to existing stakes and 0 trimmed.
- 1,179 institutional investors held Bristol-Myers Squibb (BMY) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $49.8B of Bristol-Myers Squibb stock for Q2 2013.
- 1,179 funds opened new Bristol-Myers Squibb positions in Q2 2013 and 0 closed out, a net change of +1,179 holders.
Based on aggregated 13F filings for Q2 2013.